We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current ARX market cap is 216.45M. The company's latest EPS is NZD -0.0309 and P/E is -20.39.
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
| Total Revenue | 25.08M | 22.34M | 39.68M | 63.36M | 69.07M |
| Operating Income | -1.84M | -9.98M | -7.64M | -3.11M | -10.67M |
| Net Income | -5.96M | -19.21M | -8.39M | -396k | -10.63M |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
| Total Assets | 45.96M | 79.66M | 112.65M | 116.52M | 111.06M |
| Total Liabilities | 38.36M | 21.17M | 12.16M | 14.63M | 16.12M |
| Total Equity | 7.61M | 58.49M | 100.49M | 101.89M | 94.94M |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
| Operating | 1.66M | -5.01M | -11.52M | -3.77M | -7.38M |
| Investing | -1.87M | -21.5M | -34.87M | 7.26M | 10.15M |
| Financing | -384k | 37.1M | 37.63M | -504k | -1.03M |
| Market Cap | 216.45M |
| Price to Earnings Ratio | -20.39 |
| Price to Sales Ratio | 3.13 |
| Price to Cash Ratio | 7.33 |
| Price to Book Ratio | 2.28 |
| Dividend Yield | - |
| Shares Outstanding | 343.57M |
| Average Volume (1 week) | 190.79k |
| Average Volume (1 Month) | 473.61k |
| 52 Week Change | -26.74% |
| 52 Week High | 0.995 |
| 52 Week Low | 0.475 |
| Spread (Intraday) | 0.01 (0.79%) |
| Company Name | Aroa Biosurgery Limited |
| Address |
2 kingsford smith place auckland 2022 |
| Website | https://aroabio.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
